Interleukin-6 as a biomarker in patients with hepatobiliary cancers

BACKGROUND: The role of inflammation has been well established in many cancers, including hepatobiliary cancers. Elevated levels of interleukin-6 (IL-6), a pro-inflammatory marker, are associated with poor overall survival (OS) in hepatocellular carcinoma (HCC) patients. METHODS: We performed a stud...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Gastrointest Oncol
Hauptverfasser: Gosain, Rohit, Anwar, Sidra, Miller, Austin, Iyer, Renuka, Mukherjee, Sarbajit
Format: Artigo
Sprache:Inglês
Veröffentlicht: AME Publishing Company 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534725/
https://ncbi.nlm.nih.gov/pubmed/31183205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.01.09
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge